SEATTLE, Nov. 4 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a
biotechnology company specializing in the development of innovative
therapeutic products for the treatment of cancer, today announced that Robert
Kirkman, M.D., President and Chief Executive Officer, is scheduled to present
at the Rodman & Renshaw Annual Global Investment Conference in New York City
on Tuesday, November 11, 2008 at 11:35 a.m. E.T.
